KLRK1 and breast carcinoma: Based on this point, Xu et al. synthesized this DDS to enhance the expression of various ligands (MICA/B, ULBP1, ULBP2, ULBP4) for further NKG2D activation on MDA-MB-231 cells (human breast cancer cells).